Kentucky Senate Bill 149 (Prior Session Legislation)

---

Spectrum: Bipartisan Bill
Status: Introduced on January 30 2024 - 25% progression, died in committee
Action: 2024-02-01 - to Banking & Insurance (S)
Pending: Senate Banking and Insurance Committee
Text: Latest bill text (Introduced) [PDF]

Amend KRS 304.17A-164 to establish cost-sharing requirements for prescription drugs; require rebates to be passed through; establish confidentiality requirements for the rebate information; create a new section of KRS 365.880 to 365.900 to provide that the actual amount of rebates received is a trade secret; provide that compliance with the prescription drugs cost-sharing and rebate requirements shall not be in violation of the Uniform Trade Secrets Act; amend KRS 304.17C-125, 304.38A-115, 18A.225, and 164.2871 to apply the cost-sharing and rebate requirements for prescription drugs to limited health service benefit plans, limited health service organizations, the state employee health plan, and self-insured employer group health plans provided by the governing board of a state postsecondary education institution; repeal KRS 304.38A-120, relating to assignment of certain benefits under limited health service organization plans, to consolidate like provisions; apply provisions to health plans issued or renewed on or after January 1, 2025; EFFECTIVE January 1, 2025.

AN ACT relating to prescription drugs.

Sen. Stephen Meredith [R]

Sen. Karen Berg [D]

Sen. Rick Girdler [R]

Sen. Robin Webb [D]

Date	Chamber	Action
2024-02-01	Senate	to Banking & Insurance (S)
2024-01-30	Senate	to Committee on Committees (S)
2024-01-30	Senate	introduced in Senate

Type	Source
Summary	https://apps.legislature.ky.gov/record/24RS/sb149.html
Text	https://apps.legislature.ky.gov/recorddocuments/bill/24RS/sb149/orig_bill.pdf
Supplement	https://apps.legislature.ky.gov/recorddocuments/note/24RS/sb149/LM.pdf